On June 4th and 5th, the UW Carbone Cancer Center hosted the inaugural Initiative for Theranostics and Particle Therapy (ITPT) Symposium. The ITPT, led by Jamey Weichert, PhD and Zachary Morris, MD, PhD was launched in 2024; providing personalized treatment for patients with cancer and establishing world-class programs for theranostics and particle therapy research and education.
In addition to Dr. Weichert’s involvement as co-chair, radiology faculty members Steve Y. Cho, MD; Jonathan Engle, PhD; and Amy Fowler, MD, PhD served on the initiative’s executive committee.
The symposium featured leading experts in radiochemistry, radiobiology, dosimetry, theranostics, showcasing clinical applications and latest advancements for tailored cancer treatment.
Drs. Weichert and Morris delivered opening remarks, transitioning to the keynote presentations by Steven Larson, MD, emeritus member of the Molecular Imaging and Therapy Service Department of Radiology Memorial Sloan Kettering Cancer Center and Richard Wahl, MD, professor of Radiology and Radiation Oncology at the Mallinckrodt Institute of Radiology. Additional sessions were hosted over the two-day symposium. For the full list of sessions and speakers, visit the symposium webpage.
The symposium was made possible in part by the involvement and sponsorship of key theranostic companies and the Wisconsin Alumni Research Foundation (WARF).
